Medical Marijuana in Canada: A Growth Industry

Biotech Discovers Revolutionary Immunotherapy in Houston
Source: Jason Kolbert (04/24/2025)

Coya Therapeutics Inc. (COYA:NASDAQ) recently reported a statistically significant Treg improvement in FTD patients with its dual-action immunotherapy, showing promising neuroprotection, according to a D. Boral research note.

read more >

Biopharma Company Leverages AI-Powered Platform for Cancer Breakthroughs
Source: Streetwise Reports (04/24/2025)

Rakovina Therapeutics Inc. (RKV:TSX.V) announced its scientific advisor and collaborator Dr. Artem Cherkasov was recently recognized as a leader in AI-driven drug development. Find out which analysts recently initiated coverage on the company.

read more >

Analyst Reveals Undervalued Pharmaceutical Gem in Canada
Source: Dr. Douglas Loe (04/14/2025)

In a recent research note from Leede Financial Inc. analyst Dr. Douglas Loe said Theratechnologies Inc. (TH:TSX; THTX:NASDAQ) has long term potential.

read more >

Four-Year Data on New Drug for Early AD Positive
Source: Dr. Ram Selvaraju (04/09/2025)

Long-term treatment with this small molecule seems feasible given its safety and tolerability profile, noted an H.C. Wainwright & Co. report.

read more >

Rest of 2025 Rich With Catalysts for Immunotherapy Co.
Source: Jason Kolbert (04/09/2025)

These anticipated events will advance the oncology firm's lead candidate, for lung-only metastatic osteosarcoma, toward commercialization, noted a D. Boral Capital report.

read more >